Delivery Order SPE2DB20D7066-SPE2DB25FC4BB
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,550.68 for 90 tablets of Myrbetriq ER 25 mg on December 18, 2025, with an ultimate completion date of December 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,948.30 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 25 mg tablets (90-count units) under a firm fixed-price contract. The award was made on November 3, 2025, with an ultimate completion date of November 4, 2025, and represents a non-competitive delivery against an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a $23,017.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Myrbetriq ER 50 mg tablets. The contract has an ultimate completion date of May 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a ceiling value of $15,833.37. This firm fixed-price contract, with an ultimate completion date of July 28, 2025, represents a non-set-aside competitive award. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $10,025.15 on December 22, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This firm fixed-price delivery order, with an ultimate completion date of December 23, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- AmerisourceBergen Drug Corp has been awarded a delivery order from the Defense Logistics Agency for $12,459.55 to supply Myrbetriq ER 50 mg tablets in a 90-count quantity. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and utilizes firm fixed pricing with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order represents a competitive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $36,113.23 on July 29, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 30, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Myrbetriq ER 25 mg tablets (30-count) valued at $3,773.91. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 5, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $47,128.89 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units). This firm fixed-price, non-set-aside delivery order was awarded on November 13, 2025, with an ultimate completion date of November 14, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $5,755.12. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4BBDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,868.68 for 90 tablets of Myrbetriq ER 25 mg on July 14, 2025, with ultimate completion by July 15, 2025. This non-set-aside contract employs firm fixed pricing and represents a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the contractor's Conshohocken, Pennsylvania location, the company's corporate headquarters. This award is issued under AmerisourceBergen's comprehensive pharmaceutical prime vendor IDC valued at $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as one of several key contractors supporting federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 7/14/25 |